Kalbe Farma and Kimia Farma to Open Raw Materials Plants in Indonesia
05 Jan, 2016, 06:00 GMT
JAKARTA, Indonesia, Jan. 5, 2016 /PRNewswire/ -- Vidjongtius, director of Indonesia's largest pharmaceutical company, Kalbe Farma, stated that raw material import is a big challenge for the local pharmacy industry. As a response, he declared, Kalbe Farma is currently constructing a biopharmacy raw material manufacturing plant in Cikarang, West Java, scheduled to commercially commence operations in late 2017 or 2018.
Photo - http://photos.prnewswire.com/prnh/20151230/318437
Logo - http://photos.prnewswire.com/prnh/20121014/HK92339LOGO-d
State-controlled pharmaceutical company Kimia Farma also announced recently that it would start constructing a Rp 100 billion raw materials plant in Cikarang, West Java, in 2016.
Meanwhile, in a bid to encourage the industry, the Investment Coordinating Board (BKPM) gauged a plan to allow foreign investors to hold more shares in pharmacy companies, from currently a maximum of 85 percent, to 100 percent.
Indonesia is indeed poised to become a production base for overseas and local manufacturers of medicines, including toll manufacturing.
Tailored to suit this fast changing industry, the 5th edition of CPhI South East Asia taking place during 6-8 April 2016 in Jakarta provides the must-attend trade exhibition where the regional pharma industry meets to leverage connections, knowledge and insight to spur business.
In December last year, Coordinating Economic Minister Darmin Nasution declared that the government was "not smart" if it did not support the growth of the pharmacy industry.
However, Maybank analyst Janni Asman commented that the removal of industry protection is likely to tighten the competition and lead to capped pricing power of local producers, "Most listed local pharmaceuticals are relatively less efficient than major generic producers in India and China," Janni wrote in her research.
The CPhI series of events drives growth and innovation in the global pharmaceutical industry, with leading exhibitions and online communities covering every step of the supply chain from drug discovery to finished dosage.
More than 100,000 visitors meet over 6,000 exhibitors at events in Europe, China, India, Japan, South East Asia, Russia, Brazil, Istanbul and South Korea every year to exchange ideas, form alliances and conduct business on an international scale. CPhI also provides an online buyer & supplier directory at CPhI-Online.com.
Contact Person: Ivan Ferrari
Phone Number: +62-21-2930-5959 ext 138
Email: Ivan.Ferrari@ubm.com
Related Links
SOURCE CPhI - UBM